Structure

Physi-Chem Properties

Molecular Weight:  262.07
Volume:  266.912
LogP:  3.091
LogD:  2.696
LogS:  -4.271
# Rotatable Bonds:  1
TPSA:  65.45
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.707
Synthetic Accessibility Score:  2.487
Fsp3:  0.0
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.093
MDCK Permeability:  1.4272326552600134e-05
Pgp-inhibitor:  0.045
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.415

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.359
Plasma Protein Binding (PPB):  99.4985580444336%
Volume Distribution (VD):  0.384
Pgp-substrate:  1.161363959312439%

ADMET: Metabolism

CYP1A2-inhibitor:  0.978
CYP1A2-substrate:  0.871
CYP2C19-inhibitor:  0.52
CYP2C19-substrate:  0.114
CYP2C9-inhibitor:  0.633
CYP2C9-substrate:  0.758
CYP2D6-inhibitor:  0.367
CYP2D6-substrate:  0.076
CYP3A4-inhibitor:  0.448
CYP3A4-substrate:  0.596

ADMET: Excretion

Clearance (CL):  0.625
Half-life (T1/2):  0.155

ADMET: Toxicity

hERG Blockers:  0.023
Human Hepatotoxicity (H-HT):  0.468
Drug-inuced Liver Injury (DILI):  0.973
AMES Toxicity:  0.617
Rat Oral Acute Toxicity:  0.487
Maximum Recommended Daily Dose:  0.931
Skin Sensitization:  0.6
Carcinogencity:  0.501
Eye Corrosion:  0.004
Eye Irritation:  0.891
Respiratory Toxicity:  0.882

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC209377

Natural Product ID:  NPC209377
Common Name*:   Korupensamine A
IUPAC Name:   (1R,3R)-5-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-diol
Synonyms:  
Standard InCHIKey:  JOXWHCNNDTWJPX-CHWSQXEVSA-N
Standard InCHI:  InChI=1S/C23H25NO4/c1-11-7-15-14(5-6-17(25)23(15)20(8-11)28-4)22-16-9-12(2)24-13(3)21(16)18(26)10-19(22)27/h5-8,10,12-13,24-27H,9H2,1-4H3/t12-,13-/m1/s1
SMILES:  COc1cc(C)cc2c1c(O)ccc2c1c(O)cc(c2c1C[C@@H](C)N[C@@H]2C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL487392
PubChem CID:   392421
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0002566] Isoquinolines and derivatives
        • [CHEMONTID:0002195] Naphthylisoquinolines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20256 Ancistrocladus likoko Species Ancistrocladaceae Eukaryota n.a. n.a. n.a. PMID[11076547]
NPO40017 Ancistrocladus ealaensis Species Ancistrocladaceae Eukaryota n.a. n.a. n.a. PMID[11087584]
NPO33285 ancistrocladus congolensis Species Ancistrocladaceae Eukaryota n.a. n.a. n.a. PMID[12193010]
NPO40017 Ancistrocladus ealaensis Species Ancistrocladaceae Eukaryota n.a. n.a. n.a. PMID[29560715]
NPO40017 Ancistrocladus ealaensis Species Ancistrocladaceae Eukaryota n.a. n.a. n.a. PMID[31630523]
NPO20256 Ancistrocladus likoko Species Ancistrocladaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT839 Cell Line L6 Rattus norvegicus MIC = 100.0 ug.mL-1 PMID[515831]
NPT839 Cell Line L6 Rattus norvegicus MIC = 38.0 ug.mL-1 PMID[515832]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 0.024 ug.mL-1 PMID[515831]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 0.072 ug.mL-1 PMID[515831]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 25.1 ug.mL-1 PMID[515832]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 14.5 ug.mL-1 PMID[515832]
NPT844 Organism Trypanosoma brucei rhodesiense Trypanosoma brucei rhodesiense IC50 > 1.87 ug.mL-1 PMID[515832]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 0.164 ug.mL-1 PMID[515832]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 820.0 nM PMID[515833]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC209377 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC223077
0.9935 High Similarity NPC193853
0.9935 High Similarity NPC56887
0.9677 High Similarity NPC195392
0.9671 High Similarity NPC79328
0.9608 High Similarity NPC7393
0.9608 High Similarity NPC221864
0.9545 High Similarity NPC230956
0.9545 High Similarity NPC235143
0.9545 High Similarity NPC205255
0.9545 High Similarity NPC271388
0.9545 High Similarity NPC119649
0.9484 High Similarity NPC79402
0.9484 High Similarity NPC80759
0.9477 High Similarity NPC29647
0.9264 High Similarity NPC40496
0.9264 High Similarity NPC119068
0.9207 High Similarity NPC230276
0.9207 High Similarity NPC257269
0.9161 High Similarity NPC123323
0.903 High Similarity NPC474507
0.8909 High Similarity NPC173416
0.8909 High Similarity NPC476577
0.8909 High Similarity NPC148709
0.8889 High Similarity NPC476565
0.883 High Similarity NPC259350
0.883 High Similarity NPC223236
0.8773 High Similarity NPC204947
0.8675 High Similarity NPC66341
0.8675 High Similarity NPC192135
0.8675 High Similarity NPC477020
0.8667 High Similarity NPC69712
0.8667 High Similarity NPC477562
0.8667 High Similarity NPC26240
0.8655 High Similarity NPC57036
0.8621 High Similarity NPC256124
0.8614 High Similarity NPC239775
0.8605 High Similarity NPC476576
0.8605 High Similarity NPC186546
0.8598 High Similarity NPC35627
0.8598 High Similarity NPC476573
0.8598 High Similarity NPC81247
0.8554 High Similarity NPC118274
0.8554 High Similarity NPC168753
0.8528 High Similarity NPC60186
0.8485 Intermediate Similarity NPC264850
0.8485 Intermediate Similarity NPC13916
0.8448 Intermediate Similarity NPC82457
0.8448 Intermediate Similarity NPC48490
0.8448 Intermediate Similarity NPC175890
0.8448 Intermediate Similarity NPC274661
0.8448 Intermediate Similarity NPC11296
0.8438 Intermediate Similarity NPC114124
0.8424 Intermediate Similarity NPC24465
0.8421 Intermediate Similarity NPC32413
0.8421 Intermediate Similarity NPC474506
0.8412 Intermediate Similarity NPC23219
0.84 Intermediate Similarity NPC191132
0.84 Intermediate Similarity NPC60295
0.8395 Intermediate Similarity NPC170503
0.8395 Intermediate Similarity NPC126519
0.8395 Intermediate Similarity NPC203784
0.8385 Intermediate Similarity NPC477564
0.8385 Intermediate Similarity NPC2295
0.8382 Intermediate Similarity NPC95426
0.8382 Intermediate Similarity NPC302245
0.8382 Intermediate Similarity NPC16357
0.8365 Intermediate Similarity NPC207824
0.8365 Intermediate Similarity NPC60538
0.8364 Intermediate Similarity NPC324144
0.8364 Intermediate Similarity NPC1229
0.8363 Intermediate Similarity NPC258695
0.8363 Intermediate Similarity NPC470879
0.8353 Intermediate Similarity NPC112575
0.8352 Intermediate Similarity NPC117717
0.8344 Intermediate Similarity NPC206736
0.8344 Intermediate Similarity NPC195766
0.8333 Intermediate Similarity NPC65312
0.8333 Intermediate Similarity NPC139783
0.8324 Intermediate Similarity NPC135772
0.8323 Intermediate Similarity NPC158376
0.8323 Intermediate Similarity NPC12053
0.8323 Intermediate Similarity NPC205421
0.8323 Intermediate Similarity NPC117188
0.8323 Intermediate Similarity NPC306555
0.8323 Intermediate Similarity NPC145832
0.8323 Intermediate Similarity NPC474931
0.8323 Intermediate Similarity NPC81218
0.8314 Intermediate Similarity NPC312918
0.8314 Intermediate Similarity NPC477561
0.8314 Intermediate Similarity NPC476574
0.8314 Intermediate Similarity NPC155442
0.8313 Intermediate Similarity NPC253043
0.8313 Intermediate Similarity NPC196447
0.8313 Intermediate Similarity NPC96603
0.8313 Intermediate Similarity NPC212794
0.8313 Intermediate Similarity NPC477563
0.8313 Intermediate Similarity NPC306843
0.8313 Intermediate Similarity NPC13504
0.8313 Intermediate Similarity NPC136508
0.8313 Intermediate Similarity NPC78222
0.8294 Intermediate Similarity NPC477558
0.8286 Intermediate Similarity NPC22115
0.8286 Intermediate Similarity NPC275680
0.8274 Intermediate Similarity NPC83198
0.8274 Intermediate Similarity NPC204908
0.8261 Intermediate Similarity NPC277669
0.8261 Intermediate Similarity NPC76213
0.8256 Intermediate Similarity NPC475479
0.8256 Intermediate Similarity NPC243454
0.8242 Intermediate Similarity NPC166014
0.8242 Intermediate Similarity NPC27410
0.8225 Intermediate Similarity NPC152212
0.8221 Intermediate Similarity NPC244112
0.821 Intermediate Similarity NPC26601
0.8208 Intermediate Similarity NPC239584
0.8205 Intermediate Similarity NPC470925
0.8187 Intermediate Similarity NPC329969
0.8171 Intermediate Similarity NPC186063
0.8161 Intermediate Similarity NPC49075
0.8161 Intermediate Similarity NPC271013
0.8161 Intermediate Similarity NPC15414
0.8161 Intermediate Similarity NPC42663
0.8161 Intermediate Similarity NPC90998
0.8161 Intermediate Similarity NPC229373
0.8161 Intermediate Similarity NPC328155
0.8161 Intermediate Similarity NPC104196
0.8161 Intermediate Similarity NPC7715
0.8161 Intermediate Similarity NPC54654
0.8161 Intermediate Similarity NPC239824
0.8161 Intermediate Similarity NPC8836
0.8161 Intermediate Similarity NPC222661
0.8161 Intermediate Similarity NPC290005
0.8161 Intermediate Similarity NPC251735
0.8161 Intermediate Similarity NPC185639
0.8161 Intermediate Similarity NPC217748
0.8161 Intermediate Similarity NPC182052
0.8161 Intermediate Similarity NPC258657
0.8161 Intermediate Similarity NPC311973
0.8161 Intermediate Similarity NPC181796
0.8161 Intermediate Similarity NPC290582
0.8161 Intermediate Similarity NPC285931
0.8161 Intermediate Similarity NPC279228
0.8161 Intermediate Similarity NPC223690
0.8146 Intermediate Similarity NPC478093
0.8136 Intermediate Similarity NPC206900
0.8129 Intermediate Similarity NPC232386
0.8129 Intermediate Similarity NPC152680
0.8129 Intermediate Similarity NPC190783
0.8125 Intermediate Similarity NPC476151
0.8121 Intermediate Similarity NPC476572
0.8118 Intermediate Similarity NPC6152
0.8114 Intermediate Similarity NPC167116
0.8114 Intermediate Similarity NPC254441
0.8114 Intermediate Similarity NPC274716
0.811 Intermediate Similarity NPC193949
0.811 Intermediate Similarity NPC39701
0.811 Intermediate Similarity NPC99659
0.811 Intermediate Similarity NPC204828
0.811 Intermediate Similarity NPC2413
0.811 Intermediate Similarity NPC127674
0.811 Intermediate Similarity NPC276588
0.811 Intermediate Similarity NPC249797
0.811 Intermediate Similarity NPC469817
0.811 Intermediate Similarity NPC184026
0.811 Intermediate Similarity NPC189266
0.811 Intermediate Similarity NPC5238
0.811 Intermediate Similarity NPC295691
0.811 Intermediate Similarity NPC110416
0.811 Intermediate Similarity NPC207757
0.811 Intermediate Similarity NPC325871
0.811 Intermediate Similarity NPC54379
0.811 Intermediate Similarity NPC278799
0.811 Intermediate Similarity NPC172765
0.8107 Intermediate Similarity NPC150879
0.8103 Intermediate Similarity NPC286119
0.8101 Intermediate Similarity NPC473589
0.8101 Intermediate Similarity NPC478091
0.8101 Intermediate Similarity NPC478092
0.8101 Intermediate Similarity NPC30182
0.8095 Intermediate Similarity NPC134858
0.8086 Intermediate Similarity NPC265473
0.8086 Intermediate Similarity NPC276665
0.807 Intermediate Similarity NPC149090
0.807 Intermediate Similarity NPC19520
0.8057 Intermediate Similarity NPC30779
0.8047 Intermediate Similarity NPC86144
0.8047 Intermediate Similarity NPC304659
0.8037 Intermediate Similarity NPC326316
0.8037 Intermediate Similarity NPC81733
0.8036 Intermediate Similarity NPC233650
0.8034 Intermediate Similarity NPC82763
0.8025 Intermediate Similarity NPC92541
0.8025 Intermediate Similarity NPC219162
0.8025 Intermediate Similarity NPC103379
0.8025 Intermediate Similarity NPC477565
0.8023 Intermediate Similarity NPC116465
0.8023 Intermediate Similarity NPC212237
0.8023 Intermediate Similarity NPC214116
0.8 Intermediate Similarity NPC185838

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC209377 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9264 High Similarity NPD8453 Clinical (unspecified phase)
0.8405 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD8053 Approved
0.8161 Intermediate Similarity NPD8054 Approved
0.8113 Intermediate Similarity NPD3845 Phase 1
0.7965 Intermediate Similarity NPD8099 Discontinued
0.7965 Intermediate Similarity NPD8252 Approved
0.7965 Intermediate Similarity NPD8251 Approved
0.795 Intermediate Similarity NPD7598 Phase 2
0.7919 Intermediate Similarity NPD8156 Discontinued
0.7901 Intermediate Similarity NPD4584 Approved
0.7874 Intermediate Similarity NPD7479 Phase 2
0.7857 Intermediate Similarity NPD6788 Approved
0.784 Intermediate Similarity NPD2420 Approved
0.784 Intermediate Similarity NPD2421 Approved
0.7778 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD5709 Phase 3
0.775 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD4666 Phase 3
0.7714 Intermediate Similarity NPD42 Phase 2
0.7714 Intermediate Similarity NPD6042 Phase 2
0.7683 Intermediate Similarity NPD1424 Approved
0.7683 Intermediate Similarity NPD7447 Phase 1
0.7679 Intermediate Similarity NPD7298 Approved
0.7658 Intermediate Similarity NPD2568 Approved
0.764 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7212 Phase 2
0.7622 Intermediate Similarity NPD7213 Phase 3
0.7616 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD6031 Approved
0.759 Intermediate Similarity NPD6030 Approved
0.758 Intermediate Similarity NPD4475 Approved
0.758 Intermediate Similarity NPD4474 Approved
0.7546 Intermediate Similarity NPD3977 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD6090 Discontinued
0.7529 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4727 Phase 1
0.7485 Intermediate Similarity NPD3060 Approved
0.7458 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7493 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD4625 Phase 3
0.7421 Intermediate Similarity NPD3110 Approved
0.7421 Intermediate Similarity NPD2238 Phase 2
0.7421 Intermediate Similarity NPD3109 Approved
0.7405 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD4055 Discovery
0.7396 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD5160 Discontinued
0.7391 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD6407 Approved
0.7358 Intermediate Similarity NPD6405 Approved
0.7345 Intermediate Similarity NPD27 Approved
0.7345 Intermediate Similarity NPD2489 Approved
0.7345 Intermediate Similarity NPD2898 Approved
0.7337 Intermediate Similarity NPD7906 Approved
0.733 Intermediate Similarity NPD3051 Approved
0.733 Intermediate Similarity NPD6747 Phase 1
0.7329 Intermediate Similarity NPD3054 Approved
0.7329 Intermediate Similarity NPD3052 Approved
0.7326 Intermediate Similarity NPD4585 Approved
0.7317 Intermediate Similarity NPD4256 Phase 2
0.7317 Intermediate Similarity NPD4257 Approved
0.7305 Intermediate Similarity NPD3124 Discontinued
0.7299 Intermediate Similarity NPD7831 Phase 2
0.7299 Intermediate Similarity NPD7833 Phase 2
0.7299 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD5241 Discontinued
0.7288 Intermediate Similarity NPD2969 Approved
0.7288 Intermediate Similarity NPD2970 Approved
0.7278 Intermediate Similarity NPD4908 Phase 1
0.7258 Intermediate Similarity NPD6656 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7400 Phase 3
0.7239 Intermediate Similarity NPD2156 Approved
0.7239 Intermediate Similarity NPD2154 Approved
0.7239 Intermediate Similarity NPD2155 Approved
0.7239 Intermediate Similarity NPD1753 Discontinued
0.7238 Intermediate Similarity NPD6297 Approved
0.7233 Intermediate Similarity NPD5155 Approved
0.7233 Intermediate Similarity NPD5156 Approved
0.7232 Intermediate Similarity NPD4010 Discontinued
0.7229 Intermediate Similarity NPD6748 Discontinued
0.7225 Intermediate Similarity NPD2977 Approved
0.7225 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD2978 Approved
0.7222 Intermediate Similarity NPD4097 Suspended
0.7213 Intermediate Similarity NPD4577 Approved
0.7213 Intermediate Similarity NPD4578 Approved
0.7212 Intermediate Similarity NPD7037 Approved
0.7209 Intermediate Similarity NPD4773 Phase 2
0.7209 Intermediate Similarity NPD4772 Phase 2
0.7208 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD6087 Phase 1
0.7193 Intermediate Similarity NPD4017 Approved
0.7193 Intermediate Similarity NPD4005 Discontinued
0.7189 Intermediate Similarity NPD4663 Approved
0.7186 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD2677 Approved
0.7179 Intermediate Similarity NPD6973 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD1669 Approved
0.7178 Intermediate Similarity NPD3553 Approved
0.7178 Intermediate Similarity NPD3554 Approved
0.7178 Intermediate Similarity NPD3555 Approved
0.7178 Intermediate Similarity NPD3552 Approved
0.7173 Intermediate Similarity NPD8095 Phase 1
0.717 Intermediate Similarity NPD2606 Approved
0.717 Intermediate Similarity NPD2605 Approved
0.717 Intermediate Similarity NPD3595 Approved
0.717 Intermediate Similarity NPD3594 Approved
0.7169 Intermediate Similarity NPD2460 Phase 3
0.7169 Intermediate Similarity NPD2459 Approved
0.7169 Intermediate Similarity NPD2458 Approved
0.716 Intermediate Similarity NPD3158 Phase 1
0.716 Intermediate Similarity NPD2874 Phase 2
0.716 Intermediate Similarity NPD3157 Approved
0.7158 Intermediate Similarity NPD6284 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD602 Approved
0.7152 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD599 Approved
0.7151 Intermediate Similarity NPD7693 Approved
0.7143 Intermediate Similarity NPD6667 Approved
0.7143 Intermediate Similarity NPD6666 Approved
0.7135 Intermediate Similarity NPD6071 Discontinued
0.7126 Intermediate Similarity NPD7466 Approved
0.712 Intermediate Similarity NPD7313 Approved
0.712 Intermediate Similarity NPD6146 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7311 Approved
0.712 Intermediate Similarity NPD7310 Approved
0.712 Intermediate Similarity NPD7312 Approved
0.7119 Intermediate Similarity NPD6746 Phase 2
0.7117 Intermediate Similarity NPD4579 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD2232 Approved
0.7115 Intermediate Similarity NPD2233 Approved
0.7115 Intermediate Similarity NPD2230 Approved
0.711 Intermediate Similarity NPD6072 Discontinued
0.711 Intermediate Similarity NPD7438 Suspended
0.7107 Intermediate Similarity NPD3637 Approved
0.7107 Intermediate Similarity NPD3635 Approved
0.7107 Intermediate Similarity NPD3636 Approved
0.7089 Intermediate Similarity NPD1135 Approved
0.7089 Intermediate Similarity NPD3053 Approved
0.7089 Intermediate Similarity NPD1133 Approved
0.7089 Intermediate Similarity NPD1134 Approved
0.7089 Intermediate Similarity NPD1129 Approved
0.7089 Intermediate Similarity NPD1131 Approved
0.7089 Intermediate Similarity NPD3055 Approved
0.7086 Intermediate Similarity NPD2560 Approved
0.7086 Intermediate Similarity NPD2563 Approved
0.7081 Intermediate Similarity NPD6851 Approved
0.7081 Intermediate Similarity NPD7309 Approved
0.7081 Intermediate Similarity NPD6853 Approved
0.7081 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD6107 Approved
0.7078 Intermediate Similarity NPD4093 Discontinued
0.7076 Intermediate Similarity NPD1914 Approved
0.7076 Intermediate Similarity NPD5976 Discontinued
0.7076 Intermediate Similarity NPD7427 Discontinued
0.7073 Intermediate Similarity NPD2200 Suspended
0.7066 Intermediate Similarity NPD4162 Approved
0.7066 Intermediate Similarity NPD3638 Discontinued
0.7063 Intermediate Similarity NPD596 Approved
0.7063 Intermediate Similarity NPD600 Approved
0.7059 Intermediate Similarity NPD7019 Approved
0.7059 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7020 Approved
0.7059 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD6607 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD4725 Approved
0.7048 Intermediate Similarity NPD4721 Approved
0.7048 Intermediate Similarity NPD4726 Approved
0.7044 Intermediate Similarity NPD859 Approved
0.7044 Intermediate Similarity NPD858 Approved
0.7041 Intermediate Similarity NPD3122 Phase 3
0.7041 Intermediate Similarity NPD7124 Phase 2
0.7033 Intermediate Similarity NPD6020 Phase 2
0.7033 Intermediate Similarity NPD4873 Discontinued
0.7032 Intermediate Similarity NPD2668 Approved
0.7032 Intermediate Similarity NPD2667 Approved
0.703 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD6064 Phase 1
0.7027 Intermediate Similarity NPD5895 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD3647 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD5303 Approved
0.7013 Intermediate Similarity NPD5304 Approved
0.7012 Intermediate Similarity NPD823 Approved
0.7012 Intermediate Similarity NPD2989 Phase 2
0.7012 Intermediate Similarity NPD817 Approved
0.7012 Intermediate Similarity NPD2986 Phase 2
0.7006 Intermediate Similarity NPD2561 Approved
0.7006 Intermediate Similarity NPD2562 Approved
0.7 Intermediate Similarity NPD8051 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7827 Phase 1
0.6982 Remote Similarity NPD3692 Discontinued
0.6981 Remote Similarity NPD4103 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data